fbpx

Pfizer Will Seek Approval for Third Dose of COVID-19 Vaccine

The company plans to ask the Food and Drug Administration for emergency authorization for the third dose in August

Coronavirus Pandemic

A nurse holds a bottle of the Pfizer-BioNTech COVID-19 vaccine at the Nurse Isabel Zendal Hospital in Madrid, Spain, Monday, Feb. 1, 2021. (AP Photo/Bernat Armangue)
By: Alyssa Wilson

Pfizer is getting ready to seek authorization in the United States for a third dose of its COVID-19 vaccine. 

On Thursday, the company said another dose within 12 months could boost immunity and help fight the highly transmissible variants of the disease.  

According to the Associated Press, research from multiple countries revealed the Pfizer shot and other COVID-19 vaccines offer protection against the Delta variant spreading quickly in the United States. While two doses are needed to develop the antibodies to fight COVID-19 and its variants, antibodies can dwindle over time.  

RELATED: Pfizer COVID-19 Vaccine Offers Six Months of Protection, Clinical Trial Shows 

Dr. Mikael Dolsten, the President of Research and Development at Pfizer, said early data from a study on the company’s booster shot suggest antibody levels jumped after a third dose compared to the second dose months prior.  

RELATED: Pfizer-BioNTech COVID-19 Vaccine Approved For Children Ages 12 to 15 

While Pfizer is pushing their booster shot, some medical experts aren’t too concerned about adding additional doses. Dr. William Schaffner of the Vanderbilt University Medical Center told the Associated Press that the focus is on trying to get people vaccinated. He noted that giving a third dose would be “a huge effort while we are at the moment striving to get people the first dose.”  

RELATED: ‘Vax That Thang Up’: Juvenile Remixes Hit Song to Promote COVID-19 Vaccines  

Top health experts from the Centers for Disease Control and Prevention and the Food and Drug Administration say a booster is not needed right now. They released a joint statement saying: “Americans who have been fully vaccinated do not need a booster shot at this time. FDA, CDC, and NIH are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary. This process takes into account laboratory data, clinical trial data, and cohort data-which can include data from specific pharmaceutical companies but does not rely on those data exclusively.”